Medallia Contactless Messaging Now HIPAA Compliant for Healthcare Payers, Providers and Pharmaceutical, Medical Device Companies

Patients and members benefit from contactless, mobile-messaging engagement as telehealth booms

SAN FRANCISCO--(BUSINESS WIRE)--Medallia, Inc. (NYSE: MDLA), the global leader in experience management, today announced that Medallia Zingle has achieved HIPAA compliance for the healthcare and life sciences industries. With Zingle’s mobile-messaging platform, pharmaceutical and medical device companies and healthcare payers and providers can engage in live-time, patient, member and employee experiences allowing them to minimize patient friction, simplify staff workflows and create a scalable approach to personalized patient communication.

Medallia Zingle now enables pharmaceutical companies to more easily communicate with individual patients about prescriptions, or quickly reach segments of their customers with important information. Providers have the ability to engage in two-way conversation with members or automate replies to common questions via SMS texting and popular messaging apps instead of more costly channels. Payers can proactively address issues with chronic condition populations before they become critical.

“There is no better time than the present to engage in contactless communications with patients, employees and members. Hesitation around in-person office visits is creating a boom in telehealth, and call centers are operating at an all time high. The ability to connect contactless, in real-time, about billing questions, prescriptions, clinical trials, symptoms, appointment or hospital check-ins and stays are of tremendous value right now,” said Ford Blakely, senior vice president and general manager of Medallia Zingle.

As employee experience plays an important role in optimizing patient and member experiences, Medallia Zingle improves staff recruitment, onboarding and communication with physicians and staff about company events and announcements from human resources departments in place of traditional, and often unread emails. Pharmaceutical and medical device companies can engage directly with patients and healthcare providers to ensure patients are getting access to therapies and have a direct line to drug manufacturers.

About Medallia

Medallia (NYSE: MDLA) is the pioneer and market leader in Experience Management. Medallia’s award-winning SaaS platform, the Medallia Experience Cloud, leads the market in the understanding and management of experience for customers, employees and citizens. Medallia captures experience signals created on daily journeys in person, digital and IoT interactions and applies proprietary AI technology to reveal personalized and predictive insights that can drive action with tremendous business results. Using Medallia, Experience Cloud, customers can reduce churn, turn detractors into promoters and buyers, and create in-the-moment cross-sell and up-sell opportunities, providing clear and potent returns on investment. www.medallia.com

© 2020 Medallia, Inc. All rights reserved. Medallia®, the Medallia logo, and the names and marks associated with Medallia’s products are trademarks of Medallia. All other trademarks are the property of their respective owners.